These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 27754902)
1. Posttreatment PET/CT Rather Than Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET/CT with Conventional Imaging. Bakhshi S; Bhethanabhotla S; Kumar R; Agarwal K; Sharma P; Thulkar S; Malhotra A; Dhawan D; Vishnubhatla S J Nucl Med; 2017 Apr; 58(4):577-583. PubMed ID: 27754902 [TBL] [Abstract][Full Text] [Related]
2. Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of Isik EG; Kuyumcu S; Kebudi R; Sanli Y; Karakas Z; Cakir FB; Unal SN Ann Nucl Med; 2017 Nov; 31(9):660-668. PubMed ID: 28741053 [TBL] [Abstract][Full Text] [Related]
3. Response assessment by positron emission tomography-computed tomography as compared with contrast-enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low- and middle-income countries. Kalra M; Bakhshi S; Singh M; Seth R; Verma N; Jain S; Radhakrishnan V; Mandal P; Mahajan A; Arora RS; Dinand V; Kapoor G; Sajid M; Kumar R; Taluja A; Mallick S; Chandra J Pediatr Blood Cancer; 2023 Feb; 70(2):e30091. PubMed ID: 36411263 [TBL] [Abstract][Full Text] [Related]
4. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD. Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392 [TBL] [Abstract][Full Text] [Related]
5. Combined prognostic role of TARC and interim Husi K; Pinczés LI; Fejes Z; Nagy B; Illés Á; Miltényi Z Hell J Nucl Med; 2022; 25(2):125-131. PubMed ID: 35913858 [TBL] [Abstract][Full Text] [Related]
6. International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. Biggi A; Gallamini A; Chauvie S; Hutchings M; Kostakoglu L; Gregianin M; Meignan M; Malkowski B; Hofman MS; Barrington SF J Nucl Med; 2013 May; 54(5):683-90. PubMed ID: 23516309 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. Milgrom SA; Dong W; Akhtari M; Smith GL; Pinnix CC; Mawlawi O; Rohren E; Garg N; Chuang H; Yehia ZA; Reddy JP; Gunther JR; Khoury JD; Suki T; Osborne EM; Oki Y; Fanale M; Dabaja BS Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):333-338. PubMed ID: 28068241 [TBL] [Abstract][Full Text] [Related]
9. Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. Simontacchi G; Filippi AR; Ciammella P; Buglione M; Saieva C; Magrini SM; Livi L; Iotti C; Botto B; Vaggelli L; Re A; Merli F; Ricardi U Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1077-1083. PubMed ID: 26031367 [TBL] [Abstract][Full Text] [Related]
10. 2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma. Picardi M; Fonti R; Della Pepa R; Giordano C; Pugliese N; Nicolai E; Salvatore M; Mainolfi C; Venetucci P; Rascato MG; Cappuccio I; Mascolo M; Vigliar E; Troncone G; Del Vecchio S; Pane F Eur J Cancer; 2020 Jun; 132():85-97. PubMed ID: 32334339 [TBL] [Abstract][Full Text] [Related]
11. The Utility of PET/CT in Guiding Radiotherapy Reduction for Children With Hodgkin Lymphoma Treated With ABVD. Ingley KM; Nadel HR; Potts JE; Wilson DC; Eftekhari A; Deyell RJ J Pediatr Hematol Oncol; 2020 Mar; 42(2):e87-e93. PubMed ID: 31259825 [TBL] [Abstract][Full Text] [Related]
12. Pediatric Hodgkin Lymphoma: Predictive value of interim 18F-FDG PET/CT in therapy response assessment. Ferrari C; Niccoli Asabella A; Merenda N; Altini C; Fanelli M; Muggeo P; De Leonardis F; Perillo T; Santoro N; Rubini G Medicine (Baltimore); 2017 Feb; 96(5):e5973. PubMed ID: 28151888 [TBL] [Abstract][Full Text] [Related]
13. Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection. Okosun J; Warbey V; Shaw K; Montoto S; Fields P; Marcus R; Virchis A; McNamara C; Bower M; Cwynarski K AIDS; 2012 Apr; 26(7):861-5. PubMed ID: 22333746 [TBL] [Abstract][Full Text] [Related]
14. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring. Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705 [TBL] [Abstract][Full Text] [Related]
15. Real-World Use of Positron Emission Tomography-Computed Tomography and Reported Deauville Scores in Advanced-Stage Classic Hodgkin Lymphoma: A Community Oncology Practice Perspective. Yasenchak C; Liu N; Beeks A; Fanale M; Robert N; He D; Yu KS JCO Oncol Pract; 2023 Oct; 19(10):860-870. PubMed ID: 37651672 [TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma. Cerci JJ; Pracchia LF; Linardi CC; Pitella FA; Delbeke D; Izaki M; Trindade E; Soares J; Buccheri V; Meneghetti JC J Nucl Med; 2010 Sep; 51(9):1337-43. PubMed ID: 20720036 [TBL] [Abstract][Full Text] [Related]
17. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT. Jorgov L; Montravers F; Balogova S; Ragu C; Pacquement H; Leblanc T; Abbou S; Ducou-Lepointe H; Landman-Parker J; Talbot JN Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1220-30. PubMed ID: 26660144 [TBL] [Abstract][Full Text] [Related]
18. Can Radiotherapy Be Omitted in Children With Hodgkin Lymphoma Who Achieve Metabolic Remission on Interim Positron Emission Tomography? Experience of a Tertiary Care Cancer Referral Center. Totadri S; Radhakrishnan V; Ganesan TS; Ganesan P; Kannan K; Lakshmipathy KM; Selvaluxmy G; Sagar TG J Glob Oncol; 2018 Sep; 4():1-7. PubMed ID: 30241201 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC). Fallanca F; Alongi P; Incerti E; Gianolli L; Picchio M; Kayani I; Bomanji J Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1837-48. PubMed ID: 27154522 [TBL] [Abstract][Full Text] [Related]
20. The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. Gallamini A; Barrington SF; Biggi A; Chauvie S; Kostakoglu L; Gregianin M; Meignan M; Mikhaeel GN; Loft A; Zaucha JM; Seymour JF; Hofman MS; Rigacci L; Pulsoni A; Coleman M; Dann EJ; Trentin L; Casasnovas O; Rusconi C; Brice P; Bolis S; Viviani S; Salvi F; Luminari S; Hutchings M Haematologica; 2014 Jun; 99(6):1107-13. PubMed ID: 24658820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]